Spontaneous adverse drug reaction reports for transplacental and transmammary routes in those
Conclusions
Despite many women requiring medications in pregnancy and while lactating, very few YCS reports were received over a 10 year period. Current MHRA advice is for all suspected ADRs in children following transplacental or transmammary exposure to be reported. Strategies to improve reporting in this neglected population are urgently needed.
Source: Archives of Disease in Childhood - Category: Pediatrics Authors: Russell, N.-J., Turner, M., Hawcutt, D. Tags: POSTER PRESENTATIONS Source Type: research
More News: Celexa | Children | Citalopram | Drugs & Pharmacology | Effexor | Fluoxetine | Paroxetine | Paxil | Pediatrics | Pregnancy | Prozac | Women